KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 86 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $652,000 | +3.5% | 108,884 | +0.9% | 0.00% | 0.0% |
Q1 2019 | $630,000 | -37.7% | 107,949 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $1,011,000 | -47.6% | 107,949 | -4.8% | 0.00% | -40.0% |
Q3 2018 | $1,930,000 | +0.2% | 113,349 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $1,926,000 | +66.2% | 113,349 | +31.2% | 0.01% | +66.7% |
Q1 2018 | $1,159,000 | +47.8% | 86,376 | +5.8% | 0.00% | +50.0% |
Q4 2017 | $784,000 | -9.7% | 81,670 | +3.3% | 0.00% | -33.3% |
Q3 2017 | $868,000 | +24.4% | 79,055 | +2.5% | 0.00% | +50.0% |
Q2 2017 | $698,000 | -26.2% | 77,105 | +4.6% | 0.00% | -33.3% |
Q1 2017 | $946,000 | +32.7% | 73,685 | -2.9% | 0.00% | +50.0% |
Q4 2016 | $713,000 | – | 75,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |